Renivace and blood bilirubin increased Patient Reports February 13, 2012

Renivace Side Effects Report #5584657-8
Renivace side effect was reported by a Physician from JAPAN on Dec 18, 2007. Male patient, 71 years of age, was diagnosed with hypertension, prophylaxis and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, international normalised ratio increased, liver disorder, prothrombin time prolonged. Renivace dosage: (5 MG QD ORAL). During the same period patient was treated with BAYASPIRIN, WARFARIN, DIGOXIN, MUCOSTA, MAGNESIUM OXIDE, GLYSENNID. Patient recovered.

Renivace Side Effects Report #5085260-9
Renivace side effect was reported by a Physician from ALBANIA on July 31, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5102516-1
Renivace side effect was reported by a Physician from JAPAN on Aug 23, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5413418-5
Renivace side effect was reported by a Consumer or non-health professional from JAPAN on July 25, 2007. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with cardiac failure, diabetic neuropathy and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hypokalaemia, leukopenia, neutrophil count decreased. Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with EPALRESTAT, ALDACTONE, ARTIST, DIGOSIN, LASIX, WARFARIN POTASSIUM. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #4715569-7
Renivace side effect was reported by a Physician from JAPAN on June 27, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, aspartate aminotransferase increased, beta-n-acetyl-d-glucosaminidase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic decreased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.

Renivace Side Effects Report #4737007-0
Renivace side effect was reported by a Physician from JAPAN on July 21, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.